Recent OCUL News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 08:25:34 PM
- Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD • GlobeNewswire Inc. • 10/15/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 09:32:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 09:31:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 08:20:57 PM
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/09/2024 08:05:00 PM
- Ocular Therapeutix™ to Present at October Ophthalmology Meetings • GlobeNewswire Inc. • 10/09/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:21:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:20:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:18:41 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 09:17:45 PM
- Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024 • GlobeNewswire Inc. • 09/25/2024 11:30:00 AM
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/12/2024 08:05:00 PM
- Ocular Therapeutix™ to Present at September Retina Meetings • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Ocular Therapeutix™ to Present at Two Investor Conferences in September • GlobeNewswire Inc. • 09/04/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:08:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:17:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/27/2024 08:18:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 09:10:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 08:36:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 09:32:38 PM
- Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/09/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/07/2024 08:15:05 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM